Karen L. MacDonell

TL;DR: The current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy Working Group and published by Pregnancy Hypertension to provide a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy is presented.

TL;DR: Existing international HDP CPGs have areas of consistency with which clinicians and researchers can work to develop auditable standards, and areas of inconsistency that should be addressed by future research.

TL;DR: Pregnant and postpartum women with severe hypertension are at increased risk of stroke and require blood pressure (BP) reduction, and oral agents would be ideal for use in busy and resource‐constrained settings.

TL;DR: Progress is made in the use of out-of-office blood pressure measurement as an adjunct to officeBlood pressure measurement, pre-eclampsia defined as proteinuria or relevant end-organ dysfunction, antihypertensive therapy for severe and non-severe hypertension and post-partum follow-up to mitigate the increased cardiovascular risk associated with any of the hypertensive disorders of pregnancy.

TL;DR: The APACHE II score consistently overestimates mortality risks for pregnant and recently pregnant women receiving critical care, whether they reside in HICs or LMICs, and there is a need for a pregnancy-specific outcome prediction model for these women.